Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.665 USD | +3.15% | +0.70% | -37.10% |
04-17 | Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03 | MT |
04-11 | BTIG Research Downgrades Avita Medical to Neutral From Buy | MT |
Sales 2024 * | 115M 74.81M 103M | Sales 2025 * | 164M 106M 146M | Capitalization | 334M 216M 298M |
---|---|---|---|---|---|
Net income 2024 * | -56M -36.33M -50.01M | Net income 2025 * | -17M -11.03M -15.18M | EV / Sales 2024 * | 2.72 x |
Net cash position 2024 * | 19.8M 12.84M 17.68M | Net cash position 2025 * | 1.85M 1.2M 1.66M | EV / Sales 2025 * | 2.03 x |
P/E ratio 2024 * |
-6.17
x | P/E ratio 2025 * |
-31.2
x | Employees | 207 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on AVITA Medical, Inc.
1 day | +3.15% | ||
1 week | +0.70% | ||
Current month | +2.74% | ||
1 month | -44.50% | ||
3 months | -50.77% | ||
6 months | -11.49% | ||
Current year | -37.10% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.49% | 4 M€ | -5.15% | - | |
0.00% | 34 M€ | +1.39% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 8.63 | +2.74% | 54 717 |
24-04-30 | 8.4 | -3.67% | 145,172 |
24-04-29 | 8.72 | +2.35% | 189,868 |
24-04-26 | 8.52 | +2.65% | 285,980 |
24-04-25 | 8.3 | -3.15% | 251,806 |
Delayed Quote Nasdaq, May 01, 2024 at 01:28 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.10% | 217M | |
+0.05% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.59% | 24.63B | |
-23.20% | 18.2B | |
+27.59% | 12.01B | |
-2.72% | 11.76B | |
+15.60% | 10.4B | |
-4.85% | 9.94B |
- Stock Market
- Equities
- RCEL Stock